ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "depression"

  • Abstract Number: 2824 • 2017 ACR/ARHP Annual Meeting

    Sleep and Depression Mediate the Relationship between Pain and Cognitive Dysfunction in Lupus Patients

    Teresa A. Lillis1, Vanessa Tirone1, Stacy Weinberg2, Nisarg Gandhi3, Ailda Nika4, Winston Sequeira4, Stevan E. Hobfoll1, Joel A. Block2 and Meenakshi Jolly4, 1Behavioral Sciences, Rush University Medical Center, Chicago, IL, 2Division of Rheumatology, Rush University Medical Center, Chicago, IL, 3Rush University Medical Center, Chicago, IL, 4Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: Cognitive Dysfunction (CD) is seen among 20-80% of patients with Systemic Lupus Erythematosus (SLE) and adversely affects their quality of life and productivity. Pain,…
  • Abstract Number: 2836 • 2017 ACR/ARHP Annual Meeting

    The Additional Economic Burden of Depression Among Adults with Rheumatoid Arthritis in the United States

    Nan Li and Steven Peterson, Janssen Research & Development, LLC, Spring House, PA

    Background/Purpose: Depression is significantly more prevalent in patients with rheumatoid arthritis (RA) compared with the general population.1  It has a significant effect on RA patients,…
  • Abstract Number: 607 • 2017 ACR/ARHP Annual Meeting

    Secukinumab Treatment of Psoriatic Arthritis and Moderate to Severe Psoriasis Relieves Anxiety/Depression up to 52 Weeks: An Overview from Secukinumab Phase 3 Clinical Trials

    Philip J Mease1, Mark Lebwohl2, Isabelle Gilloteau3, Todd Fox3, Jaime Oliver3, Steffen Jugl3 and Alice B Gottlieb4, 1University of Washington School of Medicine and Swedish Medical Center, Seattle, WA, 2Icahn School of Medicine at Mount Sinai, New York, NY, 3Novartis Pharma AG, Basel, Switzerland, 4Department of Dermatology, New York Medical College, Vallhalla, NY

    Background/Purpose: Secukinumab (SEC), a fully human monoclonal antibody selectively neutralizing interleukin-17A, exhibits significant efficacy, with a favorable safety profile, in the treatment of psoriatic arthritis…
  • Abstract Number: 739 • 2017 ACR/ARHP Annual Meeting

    How Effective Is the Home Exercise Program for Hands in Patients with Systemic Sclerosis: Preliminary Results from a Randomized Controlled, Single-Blind, Clinical Trial

    Neslihan Gokcen1, Suade Ozlem Badak2, Tunay Sarpel3, Yasar Sertdemir4 and Eren Erken2, 1Physical Medicine and Rehabilitation, Division of Rheumatology, Cukurova University School of Medicine, Adana, Turkey, 2Internal Medicine, Division of Rheumatology, Cukurova University School of Medicine, Adana, Turkey, 3Physical Medicine and Rehabilitation, Cukurova University School of Medicine, Adana, Turkey, 4Department of Biostatistics and Medical Informatics, Cukurova University School of Medicine, Adana, Turkey

    Background/Purpose: Systemic sclerosis (SSc) represents a heterogeneous autoimmune disease characterized by fibrosis of skin and internal organs. In particular, thickening of the skin, puffy hands,…
  • Abstract Number: 95 • 2017 Pediatric Rheumatology Symposium

    Development of Cognitive Behavioral Therapy (CBT) for Childhood-onset Systemic Lupus Erythematosus (cSLE) Treatment

    Jacqueline Warner1, Erin Moorman1, Natoshia Cunningham2, Kasha Wiley3, Allen Watts3, Susmita Kashikar-Zuck4 and Hermine Brunner5, 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Behavioral Medicine & Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 5Rheumatology, PRCSG, Cincinnati, OH

    Background/Purpose:  cSLE can result in considerable decrements in health-related quality of life (HRQOL) for young patients. Youth with cSLE experience a myriad of symptoms, including…
  • Abstract Number: 111 • 2016 ACR/ARHP Annual Meeting

    Influences of Osteoarthritis Pain, Comorbid Insomnia, and Depression on Health Care Use in Older Adults with Osteoarthritis

    Minhui Liu1, Susan M. McCurry1, Michael V. Vitiello2, Basia Belza1 and Michael Von Korff3, 1University of Washington School of Nursing, Seattle, WA, 2Psychiatry and Behavioral Sciences, Biobehavioral Nursing and Health Systems, University of Washington School of Medicine, Seattle, WA, 3Group Health Research Institute, Seattle, WA

    Background/Purpose: Osteoarthritis (OA), the most common type of arthritis, is prevalent and costly. Pain is the principal reason patients with OA seek treatment. Older adults…
  • Abstract Number: 982 • 2016 ACR/ARHP Annual Meeting

    High Financial Strain, but Not Poverty or Lower Education, Increases the Risk of Incident Depression in Systemic Lupus Erythematosus (SLE)

    Natalie McCormick1, Laura Trupin2, Edward H. Yelin2 and Patricia P. Katz2, 1Faculty of Pharmaceutical Sciences, University of British Columbia/Arthritis Research Canada, Vancouver, BC, Canada, 2Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA

    Background/Purpose: Depression is common in women with SLE.  Low socioeconomic status (SES) has been associated with prevalent depression, but the longitudinal relationship between SES and…
  • Abstract Number: 1056 • 2016 ACR/ARHP Annual Meeting

    Mind-Body Skills Training and Supportive Counseling for Depression in SLE: Positive Effects in a Randomized Controlled Trial

    Carol Greco1, Ling-Wan Chen2, Yu Cheng3, Christine McFarland4 and Susan Manzi5, 1Psychiatry, University of Pittsburgh, Pittsburgh, PA, 2Statistics, University of Pittsburgh, Pittsburgh, PA, 3Statistics and Psychiatry, UNIVERSITY OF PITTSBURGH, Pittsburgh, PA, 4Psychiatry, UNIVERSITY OF PITTSBURGH, Pittsburgh, PA, 5Lupus Center of Excellence, West Penn Allegheny Health System, Pittsburgh, PA

    Background/Purpose: Although depressive symptoms are prevalent in persons with SLE, no studies to date have evaluated psychotherapy approaches in persons with SLE who also have…
  • Abstract Number: 1511 • 2016 ACR/ARHP Annual Meeting

    Impacts of Disease Activity and Serum Level of Neurotrophic Factors on Depression in Rheumatoid Arthritis

    Young Sun Suh1, Yun-Hong Cheon2, Hyun-Ok Kim1, Hye Song Lim3, Hae Sook Noh3, Sang-Hyon Kim4, Ji-Min Kim4, Chang-Nam Son4, Seung-Geun Lee5, Eun-Kyoung Park5 and Sang-Il Lee3, 1Division of Rheumatology, Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Changwon, Korea, The Republic of, 2Division of Rheumatology, Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, Korea, The Republic of, 3Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, Korea, The Republic of, 4Division of Rheumatology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea, The Republic of, 5Division of Rheumatology, Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea, The Republic of

    Background/Purpose:  Rheumatoid arthritis (RA) and depression is closely associated with each other. The serum level of neurotrophic factors are related with the major depressive disorder…
  • Abstract Number: 1514 • 2016 ACR/ARHP Annual Meeting

    Symptoms of Depression and Anxiety Predict Worse Disease Activity and Functional Disability in a Cohort of Established Rheumatoid Arthritis Patients

    Christine Iannaccone1, Taysir G. Mahmoud2, Jing Cui3, Michael Weinblatt1 and NA Shadick4, 1Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 3Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 4Rheumatology Immunology & Allergy, Brigham & Women's Hosp, Boston, MA

    Background/Purpose: Depression and anxiety disorders are common in RA patients, with the most recent prevalence estimates indicating that 16.8% of RA patients have a diagnosis…
  • Abstract Number: 1525 • 2016 ACR/ARHP Annual Meeting

    Pain, Physical Function, and Worry (But Not Depression and Poor Sleep) Lead to Greater Fatigue in RA

    Susan J. Bartlett1, Michelle Jones2 and Clifton Bingham III3, 1Department of Medicine, Division of ClinEpi, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, 2Johns Hopkins University School of Medicine, Baltimore, MD, 3Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose:  Some view fatigue as resulting from disease activity, while others see it as a natural consequence of the pain, disability, and the emotional burden…
  • Abstract Number: 1534 • 2016 ACR/ARHP Annual Meeting

    Assessment of the Relationship of the Static and Dynamic Balance Parameters with Clinical, Functional and Radiological Findings in Patients with Rheumatoid Arthritis

    Canan Sanal Top1, M Tuncay Duruoz2 and Osman Hakan Gunduz3, 1PMR Department, Marmara University School of Medicine, Istanbul, Turkey, 2PMR Department, Rheumatology Division, Marmara University School of Medicine, Sisli-Istanbul, Turkey, 3Physical Medicine and Rehabilitation, Marmara University School of Medicine, Istanbul, Turkey

    Background/Purpose:  Lower extremity arthritis, proprioceptive dysfunction related to foot deformities, muscle weakness, joint restrictions, biomechanical disoerders, fatigue, sleep disorders, depression, and pain are frequently seen…
  • Abstract Number: 2164 • 2016 ACR/ARHP Annual Meeting

    Depression and the Risk of Psoriatic Arthritis Among Patients with Psoriasis: A Population-Based Cohort Study

    Ryan Lewinson1,2, Isabelle Vallerand1,3, Mark Lowerison3, Laurie Parsons4, Alexandra Frolkis1,3, Gilaad Kaplan3,4, Andrew Bulloch3,5,6, Scott Patten3,5 and Cheryl Barnabe3,4, 1Leaders in Medicine Program, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 2Biomedical Engineering Program, Schulich School of Engineering, University of Calgary, Calgary, AB, Canada, 3Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 4Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 5Department of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 6Department of Physiology & Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada

    Depression and the Risk of Psoriatic Arthritis among Patients with Psoriasis: A Population-based Cohort Study Background/Purpose: The factors that contribute to the development of psoriatic…
  • Abstract Number: 2438 • 2016 ACR/ARHP Annual Meeting

    Increased Risk of Postpartum Depression in SLE Pregnancies

    Evelyne Vinet1, Susan Scott2, Debbie Ehrmann Feldman3, Christian A. Pineau4 and Sasha Bernatsky2, 1Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, 2Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 3School of Rehabilitation, Université de Montréal, Montreal, QC, Canada, 4McGill University Health Centre, Montreal, QC, Canada

    Background/Purpose: Chronic diseases have been shown to be a strong risk factor for postpartum depression. Although there is a 2-fold increased risk of major depression…
  • Abstract Number: 3048 • 2016 ACR/ARHP Annual Meeting

    Pain Severity As a Mediator of the Effect of Depressive Symptoms on Physical Performance in Knee Osteoarthritis

    Alan Rathbun1, Michelle Shardell2, Michelle S. Yau3, Mona Baumgarten4, Elizabeth Stuart5 and Marc Hochberg6, 1Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, 2Translational Gerontology Branch, National Institute on Aging, Baltimore, MD, 3Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 4University of Maryland School of Medicine, Baltimore, MD, 5Mental Health, Biostatistics, and Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 6Department of Medicine, University of Maryland School of Medicine, Baltimore, MD

    Background/Purpose: Depression is a significant comorbidity of knee osteoarthritis (OA) that occurs in approximately 20% of OA patients. Depressive symptoms are associated with both subsequent…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 15
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology